First, low-molecular-weight allosteric LH/hCG-R-agonists interact with the transmembrane domain of LH/hCG-R, which undergoes fewer changes under the conditions of prolonged hyperglycemia in comparison with the ectodomain to which hCG binds. The gene discussed is PLOD1; the disease is Hyperglycemia.